Concentra Group Holdings Parent, Inc. CON

Healthcare SIC 8093 - Services-Specialty Outpatient Facilities, NEC NAICS Health Care and Social Assistance › Ambulatory Health Care Services › Outpatient Care Centers derived NYSE

We were founded in 1979 and have grown to be the largest provider of occupational health services in the United States by number of locations. Our national presence enables us to provide access to high-quality care that supports our mission to improve the health of America's workforce. As of December 31, 2025, we operated 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states. We also have expanded our reach via our telemedicine program serving 43 states and the District of Columbia. In total, we deliver services across 47 states and the District of Columbia. We had approximately 13,000 colleagues and affiliated physicians and clinicians as of December 31, 2025 who supported the delivery of an extensive suite of services, including occupational and consumer health services and other direct-to-employer care to approximately 53,000 patients each business day on average during 2025. Our patients are generally employed by our main customers — employers across the United States.

Last close 39.25 2026-10-23
Market cap $5.01B 2026-06-30 share count
52-week range 18.55 - 40.00

Valuation FY2025 figures against the last close

P/S2.3x
P/E30.2x
P/FCF25.4x
EV/EBITDA13.0x
Dividend yield0.6%
Diluted EPS1.30

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021
Revenue $2.16B$1.90B$1.84B$1.72B—
SG&A $203.3M$156.3M$152.0M$150.0M—
Total operating expenses $1.83B$1.60B$1.55B$1.47B—
Operating income $334.0M$304.8M$287.6M$258.5M—
Interest expense $109.3M$47.7M$221.0K$849.0K—
Pre-tax income $223.8M$231.4M$242.6M$224.9M—
Income tax $51.0M$59.5M$57.9M$52.7M—
Net income $166.4M$166.5M$179.9M$166.7M—
EPS, basic 1.301.461.731.60—
EPS, diluted 1.301.461.731.60—
Shares, diluted (wtd. avg.) 128.3M114.2M104.2M103.8M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021
Cash and equivalents $79.9M$183.3M$31.4M$37.7M$30.9M
Receivables $257.9M$217.7M$216.2M——
Total current assets $383.1M$437.2M$294.4M——
Goodwill $1.48B$1.23B$1.23B$1.23B—
Other intangibles $242.6M$204.7M$224.8M——
Total assets $2.86B$2.52B$2.33B$2.30B—
Accounts payable $21.0M$19.8M$20.4M——
Total current liabilities $337.2M$307.2M$274.6M——
Total liabilities $2.44B$2.22B$1.16B——
Retained earnings $146.4M$13.6M$685.3M——
Total equity $393.3M$275.7M$1.16B$979.3M$830.2M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021
Operating cash flow $279.4M$274.7M$234.3M$274.3M—
Depreciation and amortisation $49.9M$45.0M$43.0M$44.5M—
Stock-based compensation $10.5M$2.3M$651.0K$2.1M—
Capital expenditure $82.3M$64.3M$65.0M$46.0M—
Investing cash flow -$414.9M-$71.3M-$75.3M-$57.8M—
Financing cash flow $32.1M-$51.5M-$165.3M-$209.9M—
Dividends paid $32.1M$8.0M$0$0—
Buybacks $22.4M$15.4M$0$0—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0002014596-26-000029.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 1B 2B 3B Revenue, FY2022: 1.7B Net income, FY2022: 166.7M Revenue, FY2023: 1.8B Net income, FY2023: 179.9M Revenue, FY2024: 1.9B Net income, FY2024: 166.5M Revenue, FY2025: 2.2B Net income, FY2025: 166.4M FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2021FY2022FY2023FY2024FY2025
Revenue — $1.72B $1.84B $1.90B $2.16B
Gross profit — — — — —
Net income — $166.7M $179.9M $166.5M $166.4M

Recent filings and events

  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Officer or director change Item 5.02
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Other event Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8093

TickerCompanyMarket capP/ERevenue growth
ACHC Acadia Healthcare Company, Inc. $2.91B — 5.0%